Stage IVB Prostate Cancer AJCC v8 Clinical Trials in Madison, Wisconsin

4 studies are recruiting for stage ivb prostate cancer ajcc v8 in Madison, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

   This phase III trial compares the effect of adding docetaxel to hormonal therapy and apalutamide versus hormonal therapy and apalutamide alone in treating patients with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Docetaxel is …

   Stage

   Phase 3

   Ages

   18 and older

   Site

   William S Middleton VA Medical Center, Madison, Wisconsin

   Locations

   210 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT06931340 on ClinicalTrials.gov

2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

   This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective c…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   William S Middleton VA Medical Center, Madison, Wisconsin

   Locations

   341 in total

   Run by

   ECOG-ACRIN Cancer Research Group

   See if you can join NCT04423211 on ClinicalTrials.gov

3. Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

   This study investigates how well radium-223 works in treating patients with castration-resistant prostate cancer than has spread to the bones (bone metastases). Prostate cancer is the most common cancer in men and the second leading cause of cancer death. Furthermore, many men with notably advanced…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Wisconsin-Madison, Madison, Wisconsin

   Locations

   4 in total

   Run by

   University of Washington

   See if you can join NCT04489719 on ClinicalTrials.gov

4. Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

   This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places in the body (metastatic). Neuroendocrine differentiation refers to cells that have traits of both hormone-producing endoc…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin

   Locations

   13 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT05691465 on ClinicalTrials.gov